Back to search

Netherlands· NL-0a2904c64bfe

Triptofem 0,1 mg/ml, oplossing voor injectie in een voorgevulde spuit

A triptorelin product containing triptorelineacetaat 0-water, registered in Netherlands by Karmed HandelsgesmbH. The same ATC class is registered in 11 of our 19 countries.

ATC L02AE04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTriptofem 0,1 mg/ml, oplossing voor i…ATCL02AE04REGISTER NO.NL-0a2904c64bfePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Triptorelin is registered in 11 of 19 countries.

Countries holding a registration under ATC L02AE04 (triptorelin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Triptorelin · ATC L02AE04

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of triptorelin costs, country by country.

Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Triptorelin · price per daily dose (0.1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.91
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRIPTORELINEACETAAT 0-WATER
Manufacturer
Karmed HandelsgesmbH
Country
Netherlands (NL)
ATC code
L02AE04
ATC class
Triptorelin
Defined daily dose
0.1 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    110636

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

321 interactions on record for triptorelin.

Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Triptorelin · interactions on record

321 records

  • 69 severe
  • 249 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Triptorelin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All triptorelin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Pamorelin La, Salvacyl
  • Belgium · Decapeptyl, Decapeptyl Sustained Release
  • Bulgaria · Диферелин, Диферелин S.R.
  • Cyprus · Arvekap
  • Czechia · Diphereline, Diphereline S.R.
  • Germany · Pamorelin La, Salvacyl
  • Denmark · Pamorelin
  • Estonia · Diphereline
  • Spain · Decapeptyl Diario, Decapeptyl Mensual
  • Finland · Pamorelin
  • France · Decapeptyl (S.C.), Decapeptyl L.P. (I.M.) Sur 28 Jours
  • United Kingdom (Northern Ireland) · Gonapeptyl Depot
  • Greece · Arvekap, Salvapar
  • Croatia · Decapeptyl Cr
  • Hungary · Diphereline, Diphereline Sr
  • Ireland · Decapeptyl 3-Month, Decapeptyl 6-Month
  • Italy · Decapeptyl, Gonapeptyl Depot
  • Lithuania · Diphereline
  • Luxembourg · Decapeptyl, Decapeptyl Sustained Release
  • Latvia · Diphereline
  • Norway · Pamorelin
  • Poland · Diphereline, Diphereline Sr
  • Portugal · Decapeptyl, Decapeptyl Lp
  • Romania · Diphereline, Diphereline Pr
  • Sweden · Pamorelin
  • Slovenia · Diphereline, Pamorelin
  • Slovakia · Diphereline, Diphereline S.R.

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fed34c56-ba52-4f34-8a02-9f50367c9101
GET /v1/drugs/fed34c56-ba52-4f34-8a02-9f50367c9101?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h110636_smpc.pdf",
  "strength": null,
  "atc_label": "Triptorelin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg110636",
  "excipients": [
    "AZIJNZUUR (E 260)",
    "NATRIUMCHLORIDE",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "TRIPTORELINEACETAAT 0-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h110636.pdf",
  "authorised_at": "2013/01/30",
  "procedure_number": "NL/H/2441/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "110636",
  "additional_monitoring": "N"
}

See everything about triptorelin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.